Urology
Volume 75, Issue 6 , Pages 1358-1363 , June 2010

Impact of Tadalafil Once Daily in Men With Erectile Dysfunction—Including a Report of the Partners' Evaluation

  • Stanley E. Althof

      Affiliations

    • Center for Marital and Sexual Health of South Florida, West Palm Beach, Florida
    • Corresponding Author InformationReprint requests: Stanley E. Althof, Ph.D., Center for Marital and Sexual Health of South Florida, 1515 North Flagler Drive, Suite 540, West Palm Beach, FL 33401
    • ,
  • Eusebio Rubio-Aurioles

      Affiliations

    • Asociación Mexicana para la Salud Sexual, Tlalpan, Brasília, Mexico
    • ,
  • Sheryl Kingsberg

      Affiliations

    • Case Western Reserve University School of Medicine, Cleveland, Ohio
    • ,
  • Haoyue Zeigler

      Affiliations

    • Lilly, United States, LLC, Indianapolis, Indiana
    • ,
  • David G. Wong

      Affiliations

    • Lilly, United States, LLC, Indianapolis, Indiana
    • ,
  • Patrick Burns

      Affiliations

    • Lilly, United States, LLC, Indianapolis, Indiana

Received 21 July 2009 ,Accepted 14 November 2009.

References 

  1. Lue TF, Giuliano F, Montorsi F, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004;1:6–23
  2. Fisher WA, Rosen RC, Eardley I, et al. Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study. J Sex Med. 2005;2:675–684
  3. Fisher WA, Rosen RC, Mollen M, et al. Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med. 2005;2:699–708
  4. Goldstein I, Fisher WA, Sand M, et al. Vardenafil Study Group Women's sexual function improves when partners are administered vardenafil for erectile dysfunction: a prospective, randomized, double-blind, placebo-controlled trial. J Sex Med. 2005;2:819–832
  5. Althof SE, Eid JF, Talley DR, et al. Through the eyes of women: the partners' perspective on tadalafil. Urology. 2006;68:631–635
  6. Rosen RC, Fisher WA, Beneke M, et al. The COUPLES-project: a pooled analysis of patient and partner treatment satisfaction scale (TSS) outcomes following vardenafil treatment. BJU Int. 2007;99:849–859
  7. Brock G, Chan J, Carrier S, et al. The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners. BJU Int. 2007;99:376–382
  8. Conaglen HM, Conaglen JV. Investigating women's preferences for sildenafil or tadalafil use by their partners with erectile dysfunction: the partners' preference study. J Sex Med. 2008;5:1198–1207
  9. Rubio-Aurioles E, Kim ED, Rosen RC, et al. Impact on erectile function and sexual quality of life of couples: a double-blind, randomized, placebo-controlled trial of tadalafil taken once daily. J Sex Med. 2009;6:1314–1323
  10. Seftel AD, Buvat J, Althof SE, et al. Improvements in confidence, sexual relationship, and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily. Int J Impot Res. 2009;21:240–248
  11. Dean J, Rubio-Aurioles E, McCabe M, et al. Integrating partners into erectile dysfunction treatment: improving the sexual experience for the couple. Int J Clin Pract. 2008;62:127–133
  12. Montorsi F, Althof SE. Partner responses to sildenafil citrate (Viagra) treatment of erectile dysfunction. Urology. 2004;63:762–767
  13. Riley A. The role of the partner in erectile dysfunction and its treatment. Int J Impot Res. 2002;14(suppl 1):S105–S109
  14. Porst H, Giuliano F, Glina S, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind placebo-controlled trial. Eur Urol. 2006;50:351–359
  15. Rajfer J, Aliotta PJ, Steidle CP, et al. Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res. 2007;19:95–103
  16. Hatzichristou D, Gambla M, Rubio-Aurioles E, et al. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabet Med. 2008;25:138–146
  17. Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–830
  18. Cappelleri JC, Rosen RC, Smith MD, et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology. 1999;54:346–351
  19. Rosen RC, Cappelleri JC, Gendrano N3rd. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14:226–244
  20. Rubio-Aurioles E, Sand M, Terrein-Roccatti N, et al. Female assessment of male erectile dysfunction detection scale (FAME): development and validation. J Sex Med. 2009;6:2255–2270
  21. Shifren JL, Monz BU, Russo PA, et al. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008;112:970–978
  22. Flyckt R, Kingsberg SA. Sexuality and aging. In: Stuart I, ed. Handbook of Gerontology. London: Cambridge University Press; in press.
  23. Avis NE, Stellato R, Crawford S, et al. Is there an association between menopause status and sexual functioning?. Menopause. 2000;7:297–309
  24. Hartmann U, Philippsohn S, Heiser K, et al. Low sexual desire in midlife and older women: personality factors, psychosocial development, present sexuality. Menopause. 2004;11(6 Pt. 2):726–740
  25. Woodward JM, Hass SL, Woodward PJ. Reliability and validity of the sexual life quality questionnaire (SLQQ). Qual Life Res. 2002;11:365–377
  26. Cappelleri JC, Althof SE, Siegel RL, et al. Development and validation of the self-esteem and relationship (SEAR) questionnaire in erectile dysfunction. Int J Impot Res. 2004;16:30–38
  27. Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208
  28. Althof SE, Corty EW, Levine SB, et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology. 1999;53:793–799
  29. Perelman MA. Sex coaching for physicians: combination treatment for patient and partner. Int J Impot Res. 2003;15(suppl 5):S67–S74
  30. Conaglen HM, Conaglen JV. The impact of erectile dysfunction on female partners: a qualitative investigation. Sex Relat Ther. 2008;23:147–156

 This work was supported by Lilly, United States, LLC, including assistance with manuscript preparation provided by Danette Hann, PhD (i3 Statprobe).

 Dr. Althof is consultant or adviser for Pfizer, Palitan, GSK, Eli Lilly, Boehringer-Ingelheim, Johnson and Johnson, Plethora and a Principal Investigator for Boehringer-Ingelheim and Plethora.

 Dr. Rubio-Aurioles is currently a consultant, investigator and speaker for Eli Lilly, Bayer Schering, Boehringer-Ingelheim, and More Pharma, Mexico.

 Dr. Kingsberg is an investigator for BioSante, Procter & Gamble, Boehringer-Ingelheim, a consultant for Wyeth and Boehringer-Ingelheim, on the speakers bureau for Eli Lilly, and has received honoraria from Johnson & Johnson.

 Mrs. Zeigler is an employee of Lilly USA, LLC.

 Dr. Wong and Dr. Burns are employees of Lilly, United States, LLC and own stock in the company.

PII: S0090-4295(09)03108-2

doi: 10.1016/j.urology.2009.11.066

Urology
Volume 75, Issue 6 , Pages 1358-1363 , June 2010

Article Tools

* Image Usage & Resolution